Linagliptin is more effective than glimepiride at achieving a composite outcome of target HbA 1c < 7% with no hypoglycaemia and no weight gain over 2 years

✍ Scribed by Gallwitz, B.; Rosenstock, J.; Emser, A.; von Eynatten, M.; Woerle, H.-J.

• Book ID: 124053702
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 154 KB
• Volume: 67
• Category: Article
• ISSN: 1368-5031
• DOI: 10.1111/ijcp.12101